Yi-Hsin Chen

Dr. Yi-Hsin Chen

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YCYi-Hsin Chen
Yi-Hsin Chen
KWKanghsi Wu
Kanghsi Wu
HWHan-Ping Wu
Han-Ping Wu
Toll-like receptors (TLRs) are vital components of the innate immune system, serving as the first line of defense against pathogens by recognizing a wide array of molecular patterns. This review summarizes the critical roles of TLRs in immune surveillance and disease pathogenesis, focusing on their structure, signaling pathways, and implications in various disorders. We discuss the molecular intricacies of TLRs, including their ligand specificity, signaling cascades, and the functional consequences of their activation. The involvement of TLRs in infectious diseases, autoimmunity, chronic inflammation, and cancer is explored, highlighting their potential as therapeutic targets. We also examine recent advancements in TLR research, such as the development of specific agonists and antagonists, and their application in immunotherapy and vaccine development. Furthermore, we address the challenges and controversies surrounding TLR research and outline future directions, including the integration of computational modeling and personalized medicine approaches. In conclusion, TLRs represent a promising frontier in medical research, with the potential to significantly impact the development of novel therapeutic strategies for a wide range of diseases.

6 September 2024 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
WWWei-Yao Wang
Wei-Yao Wang
CCChen-Feng Chiu
Chen-Feng Chiu
STShih-Ming Tsao
Shih-Ming Tsao
YLYu-Lin Lee
Yu-Lin Lee
YCYi-Hsin Chen
Yi-Hsin Chen

5 May 2026 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
MCMing-I Chen
Ming-I Chen
YHYing-Lin Hsu
Ying-Lin Hsu
YCYi-Hsin Chen
Yi-Hsin Chen

12 September 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
HYHsun Yang
Hsun Yang
SJShiun-Yang Juang
Shiun-Yang Juang
KLKuan-Fu Liao
Kuan-Fu Liao
YCYi-Hsin Chen
Yi-Hsin Chen
Background: We hypothesized that the nutrient loss and chronic inflammation status may stimulate progression in advanced chronic kidney disease. Therefore, we aimed to generate a study to state the influence of combined nutritional and anti-inflammatory interventions. Methods: The registry from the National Health Insurance Research Database in Taiwan was searched for 20–90 years individuals who had certified end-stage renal disease. From January 2005 through December 2010, the diagnosis code ICD-9 585 (chronic kidney disease, CKD) plus erythropoiesis-stimulating agent (ESA) use was defined as entering advanced chronic kidney disease. The ESA starting date was defined as the first index date, whereas the initiation day of maintenance dialysis was defined as the second index date. The duration between the index dates was analyzed in different medical treatments. Results: There were 10,954 patients analyzed. The combination therapy resulted in the longest duration (n = 2184, median 145 days, p < 0.001) before the dialysis initiation compared with folic acid (n = 5073, median 111 days), pentoxifylline (n = 1119, median 102 days, p = 0.654), and no drug group (control, n = 2578, median 89 days, p < 0.001). Lacking eGFR data and the retrospective nature are important limitations. Conclusions: In patients with advanced CKD on the ESA treatment, the combination of folic acid and pentoxifylline was associated with delayed initiation of hemodialysis.

17 May 2024 in Kidney Medicine
Verified
Journal Article
Open access
YCYi-Hsin Chen
Yi-Hsin Chen
CCChih-Tsung Chen
Chih-Tsung Chen
Intradialytic hypotension significantly affects patient safety and clinical outcomes during hemodialysis. Despite various pharmacological and nonpharmacological interventions, effective management remains elusive. In this report, we detail a case of intradialytic hypotension in a male patient in his 40s, undergoing hemodialysis with a history of polycystic kidney disease. Eight years ago, the patient underwent bilateral nephrectomy because of a severe cystic infection, after which his systolic blood pressure (BP) persistently remained at 50-70 mm Hg during dialysis sessions. The initial treatment strategy for hypotension included fludrocortisone, midodrine, and prednisolone, leading to a slight temporary increase in BP, which subsequently declined. As the patient’s condition deteriorated, the administration of norepinephrine or dopamine became necessary to sustain BP during dialysis. Given the patient’s resistance to these treatments, a daily dose of 25 mg of atomoxetine was introduced. Following this treatment, there was a gradual improvement in the patient’s vertigo, weakness, and BP. This case illustrates that low-dose atomoxetine can alleviate symptoms and elevate BP in patients experiencing severe intradialytic hypotension during hemodialysis.

26 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MCMing-I Chen
Ming-I Chen
YSYin-Tzer Shih
Yin-Tzer Shih
YHYing-Lin Hsu
Ying-Lin Hsu
YCYi-Hsin Chen
Yi-Hsin Chen
Bacterial resistance, driven by excessive antibiotic use, has rendered many traditional antibiotics ineffective. Despite the advantages of applying matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to predict bacterial antimicrobial resistance, limited databases and a lack of high-quality data hinder this effort. This study aimed to address this lack of data by integrating MALDI-TOF MS technology with transfer learning approaches, utilizing genus-level data, to predict species-specific bacterial antimicrobial resistance. The data were retrieved from the DRIAMS dataset. A multilayer perceptron deep neural network was applied for pretraining and fine-tuning, integrating genus-level data to enhance the accuracy of the species-specific predictions. Notably, fine-tuned models enhanced antibiotic resistance prediction. In Staphylococcus aureus , the area under the receiver operating characteristic curve (AUROC) improved from 0.95 to 0.96 and the area under the precision-recall curve (AUPRC) improved from 0.85 to 0.88 for oxacillin; for fusidic acid, the AUROC improved from 0.80 to 0.81 and the AUPRC from 0.32 to 0.36; and for ciprofloxacin, the AUROC improved from 0.80 to 0.82 while the AUPRC remained 0.57. In Klebsiella pneumoniae , the AUROC held steady at 0.75, while the AUPRC declined from 0.45 to 0.41 for ciprofloxacin, indicating potential limitations for certain pathogen-antibiotic combinations. Despite such variability, the overall improvements across multiple strains highlight the potential of transfer learning in antimicrobial resistance prediction and underscore the need to expand genus-level databases to improve species-level diagnostic accuracy, thereby enhancing clinical diagnostics.